Gargalionis AN, Papavassiliou KA, Papavassiliou AG. Mechanobiology of solid tumors. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166555.
Google ScholarÂ
Deng B, Zhao Z, Kong W, Han C, Shen X, Zhou C. Biological role of matrix stiffness in tumor growth and treatment. J Transl Med. 2022;20:540.
Google ScholarÂ
Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, Somasegar S, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci USA 2017;114:492–7.
Wei SC, Fattet L, Tsai JH, Guo Y, Pai VH, Majeski HE, et al. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol. 2015;17:678–88.
Google ScholarÂ
Lampi MC, Reinhart-King CA. Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials. Sci Transl Med. 2018;10:eaao0475.
Google ScholarÂ
Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–16.
Google ScholarÂ
Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380:1450–62.
Google ScholarÂ
Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 2012;56:769–75.
Google ScholarÂ
Filliol A, Schwabe RF. Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis. Semin Liver Dis. 2019;39:315–33.
Google ScholarÂ
Li M, Zhang X, Wang M, Wang Y, Qian J, Xing X, et al. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma. Cancer Commun. 2022;42:1162–84.
Google ScholarÂ
Wang S, Chen L, Liu W. Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma. Cancer Cell Int. 2022;22:318.
Google ScholarÂ
Wei J, Yao J, Yang C, Mao Y, Zhu D, Xie Y, et al. Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma. J Transl Med. 2022;20:555.
Google ScholarÂ
Wong CC, Tse AP, Huang YP, Zhu YT, Chiu DK, Lai RK, et al. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 2014;60:1645–58.
Google ScholarÂ
Zhao W, Mo H, Liu R, Chen T, Yang N, Liu Z. Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression. Br J Cancer. 2022;127:202–10.
Google ScholarÂ
Dong Y, Zheng Q, Wang Z, Lin X, You Y, Wu S, et al. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. J Hematol Oncol. 2019;12:112.
Google ScholarÂ
Liu HH, Xu Y, Li CJ, Hsu SJ, Lin XH, Zhang R, et al. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. Mol Ther. 2022;30:2554–67.
Google ScholarÂ
Haage A, Schneider IC. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells. FaSEB J. 2014;28:3589–99.
Ondeck MG, Kumar A, Placone JK, Plunkett CM, Matte BF, Wong KC, et al. Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling. Proc Natl Acad Sci USA 2019;116:3502–7.
Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891–906.
Google ScholarÂ
Kim KH, Son JH. PINK1 gene knockdown leads to increased binding of parkin with actin filament. Neurosci Lett. 2010;468:272–6.
Google ScholarÂ
RodrÃguez-Pérez F, Manford AG, Pogson A, Ingersoll AJ, MartÃnez-González B, Rape M. Ubiquitin-dependent remodeling of the actin cytoskeleton drives cell fusion. Dev Cell. 2021;56:588–601.e589.
Google ScholarÂ
Dou C, Liu Z, Tu K, Zhang H, Chen C, Yaqoob U, et al. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts. Gastroenterology. 2018;154:2209–21.e2214.
Google ScholarÂ
Zhou SL, Zhou ZJ, Hu ZQ, Song CL, Luo YJ, Luo CB, et al. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. J Hepatol. 2019;71:1152–63.
Google ScholarÂ
Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 2013;144:1066–75.e1061.
Google ScholarÂ
Bukoreshtliev NV, Haase K, Pelling AE. Mechanical cues in cellular signalling and communication. Cell Tissue Res. 2013;352:77–94.
Google ScholarÂ
Holzinger A. Jasplakinolide: an actin-specific reagent that promotes actin polymerization. Methods Mol Biol. 2009;586:71–87.
Google ScholarÂ
Chen MB, Javanmardi Y, Shahreza S, Serwinski B, Aref A, Djordjevic B, et al. Mechanobiology in oncology: basic concepts and clinical prospects. Front Cell Dev Biol. 2023;11:1239749.
Google ScholarÂ
Gallotti A, D’Onofrio M, Romanini L, Cantisani V, Pozzi Mucelli R. Acoustic Radiation Force Impulse (ARFI) ultrasound imaging of solid focal liver lesions. Eur J Radio. 2012;81:451–5.
Alomari M. TRIM21 – A potential novel therapeutic target in cancer. Pharm Res. 2021;165:105443.
Google ScholarÂ
Wang H, Zhou Y, Oyang L, Han Y, Xia L, Lin J, et al. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma. Oncogene. 2019;38:5062–75.
Google ScholarÂ
Liu J, Zhang C, Xu D, Zhang T, Chang CY, Wang J, et al. The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. J Clin Invest. 2023;133:e164354.
Jin Y, Zhang Y, Li B, Zhang J, Dong Z, Hu X, et al. TRIM21 mediates ubiquitination of Snail and modulates epithelial to mesenchymal transition in breast cancer cells. Int J Biol Macromol. 2019;124:846–53.
Google ScholarÂ
Ding Q, He D, He K, Zhang Q, Tang M, Dai J, et al. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers. Tumour Biol. 2015;36:8761–72.
Google ScholarÂ
Zhang Z, Zhu Z, Sheng H, Sun J, Cao C. TRIM21 suppresses invasion of hepatocellular carcinoma cells by promoting β-catenin ubiquitylation and degradation. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:55–62.
Google ScholarÂ
Wang F, Zhang Y, Shen J, Yang B, Dai W, Yan J, et al. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway. Cell Mol Gastroenterol Hepatol. 2021;11:1369–85.
Google ScholarÂ
Lekka M, Pabijan J, Orzechowska B. Morphological and mechanical stability of bladder cancer cells in response to substrate rigidity. Biochim Biophys Acta Gen Subj. 2019;1863:1006–14.
Google ScholarÂ
Ma X, Dang Y, Shao X, Chen X, Wu F, Li Y. Ubiquitination and long non-coding RNAs regulate actin cytoskeleton regulators in cancer progression. Int J Mol Sci. 2019;20:2997.
Google ScholarÂ
Park JS, Burckhardt CJ, Lazcano R, Solis LM, Isogai T, Li L, et al. Mechanical regulation of glycolysis via cytoskeleton architecture. Nature. 2020;578:621–6.
Google ScholarÂ
Gu L, Zhu Y, Lin X, Tan X, Lu B, Li Y. Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. 2020;39:2437–49.
Google ScholarÂ
Cheng Y, He J, Zuo B, He Y. Role of lipid metabolism in hepatocellular carcinoma. Discov Oncol. 2024;15:206.
Google ScholarÂ
